technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cardiomyopathies in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| González-Robledo, G; Lizarazo Ortega, DA; Trujillo, PB; Valderrama, BP | 1 |
| Autore, C; Bonfiglioli, R; Canepa, M; Cappelli, F; Di Bella, G; Grandis, M; Luigetti, M; Milandri, A; Musumeci, MB; My, F; Perfetto, F; Perlini, S; Rapezzi, C; Russo, D; Tini, G | 1 |
| Ikebe, S; Morioka, M; Nishi, M; Takashio, S; Tsujita, K | 1 |
| Cuscaden, C; Goodwin, B; Prasad, S; Ramsay, SC; Smith, J | 1 |
| Padrón, K; Peix, A | 1 |
| Blokzijl, H; Dierckx, RA; Glaudemans, AW; Hazenberg, BP; Koole, M; Noordzij, W; Slart, RH; van den Berg, MP; van Rheenen, RW | 1 |
| Bodez, D; Cottereau, AS; Damy, T; Dubois-Randé, JL; Galat, A; Guellich, A; Guendouz, S; Hittinger, L; Itti, E; Meignan, M; Plante-Bordeneuve, V; Rosso, J; Van der Gucht, A | 1 |
| Kulhanek, J; Movahed, A | 1 |
| Fujiwara, Y; Hamada, M; Hiwada, K; Kobayashi, T; Matsuoka, H; Sekiya, M; Sumimoto, T | 1 |
| Fig, LM; Gross, MD; Gupta, AK; Meyer, P; Shapiro, B | 1 |
| Hashimoto, K; Sakuta, M; Sonoh, M; Tamaoka, A | 1 |
11 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cardiomyopathies
| Article | Year |
|---|---|
A Case of Wild-type Cardiac Transthyretin Amyloidosis Diagnosed by Non-invasive Methods.
Topics: Aged, 80 and over; Amyloid Neuropathies, Familial; Aortic Valve Stenosis; Cardiomyopathies; Female; Humans; Prealbumin; Stroke Volume; Ventricular Function, Left | 2023 |
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Topics: Aged; Amyloid Neuropathies, Familial; Bone and Bones; Cardiomyopathies; Diphosphonates; Female; Genetic Predisposition to Disease; Humans; Italy; Male; Middle Aged; Mutation; Prealbumin; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Technetium Compounds; Technetium Tc 99m Medronate; Whole Body Imaging | 2020 |
Transthyretin Amyloid Cardiomyopathy Diagnosed on Incidental Myocardial Uptake During Bone Scintigraphy.
Topics: Aged, 80 and over; Amyloid Neuropathies, Familial; Bone Neoplasms; Cardiomyopathies; Genetic Predisposition to Disease; Humans; Incidental Findings; Male; Mutation; Prealbumin; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Whole Body Imaging | 2020 |
Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
Topics: Aged; Aged, 80 and over; Amyloidosis; Australia; Bone and Bones; Cardiomyopathies; Correlation of Data; Diphosphonates; Echocardiography; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Prealbumin; Prevalence; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate | 2021 |
Imagine, believe, and achieve.
Topics: Amyloidosis; Biomarkers; Biopsy; Bone and Bones; Cardiomyopathies; Heart; Humans; Image Enhancement; Multimodal Imaging; Prealbumin; Radionuclide Imaging; Risk Assessment; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate | 2021 |
Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Bone and Bones; Cardiomyopathies; Early Diagnosis; Female; Heart Ventricles; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution | 2014 |
Early Phase
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diagnosis, Differential; Genetic Predisposition to Disease; Humans; Immunoglobulin Light-chain Amyloidosis; Mutation; Prealbumin; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2017 |
Uptake of technetium 99m HDP in cardiac amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Echocardiography; Female; Humans; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2003 |
A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.
Topics: Aged; Amyloidosis; Cardiomyopathies; Humans; Male; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon | 1993 |
Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.
Topics: Aged; Amyloidosis; Bone and Bones; Bone Neoplasms; Cardiomyopathies; Heart; Humans; Male; Multiple Myeloma; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1998 |
[Primary systemic amyloidosis with polyneuropathy as the major symptom demonstrating marked myocardial uptake of technetium-99m-hydroxy methylene diphosphonate].
Topics: Amyloidosis; Cardiomyopathies; Humans; Male; Middle Aged; Myocardium; Peripheral Nervous System Diseases; Radionuclide Imaging; Technetium Tc 99m Medronate | 1986 |